Life Science Tools, MDx M&A Flat in 2011; Improvement Ahead? | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – The number of mergers and acquisitions in the genomics tools and molecular diagnostics markets in 2011 was flat compared to 2010 as a strong start to the year fizzled out in the second half.

Despite the late-year lull, some experts are predicting a rebound in M&A activity over the next couple of years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.